Stock Price Quote

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE923.907.4 (+0.81 %)
PREV CLOSE ( ) 916.50
OPEN PRICE ( ) 918.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9452
TODAY'S LOW / HIGH ( )912.25 938.00
52 WK LOW / HIGH ( )450 995.05
NSE924.407.2 (+0.78 %)
PREV CLOSE( ) 917.20
OPEN PRICE ( ) 914.10
BID PRICE (QTY) 924.40 (5648)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 492226
TODAY'S LOW / HIGH( ) 910.10 937.90
52 WK LOW / HIGH ( )402.55 996
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500003

Phone 040-23547532

Email investors@natcopharma.co.in / dasaradhi@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE, NSE, MCX

NEWS

16Oct Hero MotoCorp, M&M and Persistent Syst
Hero MotoCorp has launched the new Pleasure plus Platinum, delivering it..
16Oct Natco Pharma aims to launch around 10
Natco Pharma is aiming to launch around 10 new products every year in th..
16Oct Natco Pharma moves up on aiming to lau
Natco Pharma is currently trading at Rs. 883.25, up by 6.50 points or 0...
25Sep Natco Pharma informs about disclosure
Natco Pharma has informed that the exchange has received the disclosure..
22Sep SBI Life Insurance, IOC and Natco Phar
SBI Life Insurance Company has signed bancassurance agreement with Yes B..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit12674745
Gross Profit 1616 5831
Operating Profit 19257018
Net Sales 532217902

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE)
peergroup  2708.15 (1.27%)
M.Cap ( in Cr)45824.26
Ajanta Pharma (BSE)
peergroup  1572.70 (1.76%)
M.Cap ( in Cr)13723.58
Astrazeneca Pharma I (BSE)
peergroup  4314.55 (0.55%)
M.Cap ( in Cr)10786.38
Glaxosmithkline Phar (BSE)
peergroup  1538.15 (1.26%)
M.Cap ( in Cr)26057.19
Dr. Reddys Lab (BSE)
peergroup  5069.35 (0.35%)
M.Cap ( in Cr)84287.72

Shareholding Pattern

MUTUAL FUNDS/UTI 9.26%
PROMOTERS 48.91%
NON-INSTITUTION 18.07%
FI/BANKS/INSURANCE 0.19%
FII 0.01%
GOVERNMENT 0%

About Natco Pharma Ltd.

Natco Pharma Ltd. was incorporated in the year 1981. Its today's share price is 923.9. Its current market capitalisation stands at Rs 16832.2 Cr. In the latest quarter, company has reported Gross Sales of Rs. 20582 Cr and Total Income of Rs.20224 Cr. The company's management includes Sridhar Sankararaman, D Linga Rao, PSRK Prasad, Rajeev Nannapaneni, MUR Naidu, Leela Digumarti, DG Prasad, TV Rao, G S Murthy, V C Nannapaneni, V C Nannapaneni.

It is listed on the BSE with a BSE Code of 524816 , NSE with an NSE Symbol of NATCOPHARM and ISIN of INE987B01026. It's Registered office is at Natco House,Road No 2,Banjara HillsHyderabad-500003, Telangana. Their Registrars are ACC Ltd. It's auditors are Brahmayya & Co, BSR & Associates LLP, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)